Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Montelukast Sodium NDC 53002-4730 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - lbl530024730

Label Image - lbl530024730

montelukast-fig1.jpg - montelukast fig1

montelukast-fig1.jpg - montelukast fig1

The text describes Figure 1 which displays the change in height in centimeters from the baseline visit over different weeks on treatment for three groups - nontelukast 5 mg, beclomethasone 336 µg, and placebo. The standard errors of the treatment group means in change in height are too small to be visible on the plot.*

montelukast-fig2.jpg - montelukast fig2

montelukast-fig2.jpg - montelukast fig2

This is a graph (Figure 2) that shows the mean percent change from baseline in forced expiratory volume (FEV) in a clinical trial conducted in the United States. The trial participants were divided into two groups- one group was given Montelukast Sodium while the other group was given a placebo. The graph shows the percent change in FEV for both groups over 15 weeks of treatment and a washout period. The horizontal axis represents the weeks of treatment, while the vertical axis represents the mean percent change from baseline. The trial involved 406 individuals who were given Montelukast Sodium and 270 individuals who were given a placebo.*

Chemical Structure - montelukast str

Chemical Structure - montelukast str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.